How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | KBLBKraig Biocraft Laboratories, Inc. | MATVMativ Holdings, Inc. | PCTPureCycle Technologies, Inc. | TROXTronox Holdings plc | Median of the restexcluding KBLB |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $0.081▲ 0.00 (1.25%) | $12.25▲ 0.51 (4.34%) | $2.78▲ 0.01 (0.36%) | $3.48▲ 0.22 (6.75%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 2.0/10 | 5.0/10 | 2.0/10 | 2.0/10 | 2.0/10 |
| Market value | $84.5M | $669.8M | $501.2M | $551.8M | |
| Revenue | — | $1.99B | $8.4M | $2.90B | |
| Profit | -$3.6M | -$337.4M | -$182.6M | -$470.0M | |
| Revenue growthChange in sales versus the prior year. | — | 0.3% | — | -5.7% | -2.7% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 18.3% | — | 9.3% | 13.8% |
| Operating marginShare of sales left after running the business, before interest and tax. | — | -19.3% | -2171.6% | -8.7% | -19.3% |
| Profit marginProfit kept from each dollar of sales. | — | -17.0% | -2185.1% | -16.2% | -17.0% |
| Free cash flow marginCash left after capital spending, as a share of sales. | — | 4.7% | -2197.3% | -9.7% | -9.7% |
| Return on equityProfit against the owners' stake in the company. | 45.3% | -67.7% | -397.9% | -33.1% | -67.7% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | -21.2% | — | -4.6% | -12.9% |
| P/E ratioPrice paid per dollar of annual profit. | — | — | — | — | — |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | — | 71.91x | 71.91x |
| Price to book | -10.56x | 1.34x | 10.92x | 0.39x | 1.34x |
| Debt to equityTotal liabilities compared with owners' stake. | -1.32x | 3.11x | 12.47x | 3.36x | 3.36x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 3/6 | 4/9 | 4/7 | 3/9 | 4.0 |
| Bankruptcy riskAltman Z-Score zone. | not reported | distress | distress | distress |
How KBLB compares with the others
- Its liabilities are lower relative to equity than the median of the other companies selected: -1.3x against 3.4x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.